Bioavailability and Delivery of Nutraceuticals and Functional Foods Using Nanotechnology

Bio-Nanotechnology: A Revolution in Food, Biomedical and Health Sciences

Volumn , Issue , 2013, Pages 593-604

  Yu, Hailong ^a   Huang, Qingrong ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

AUC, absolute bioavailability; Bioavailability, three steps; Bioavailability delivery; Bioavailability pathogen control; Functional foods, regulatory status; Nano, for oral bioavailability; Nanoemulsions; Nutraceutical bioavailability; Nutraceuticals, signaling molecules; Nutraceuticals functional foods

Indexed keywords

EID: 84887184533     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118451915.ch35     Document Type: Chapter

References (44)

1. Institute of Food Technologists, Functional Foods: Opportunities and Challenges. Institute of Food Technologists, 2005.
2. Food and Agriculture Organization of the United Nations, Report on Functional Foods: Food Quality and Standards Services. FAO, 2007.
3. Cui, J.; Yu, B.; Zhao, Y.; Zhu, W. W.; Li, H. L.; Lou, H. X.; Zhai, G. X., Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int. J. Pharm. 371 (1-2), 148-155 (2009).
4. Corson, T. W.; Crews, C. M., Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell. 130 (5), 769-774 (2007).
5. Halliwell, B.; Rafter, J.; Jenner, A., Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am. J. Clin. Nutr. 81 (1), 268S-276S (2005).
6. Howitz, K. T.; Sinclair, D. A., Xenohormesis: sensing the chemical cues of other species. Cell 133 (3), 387-391 (2008).
7. Jambhekar, S. S.; Breen, P. J., Basic Pharmacokinetics. Pharmaceutical Press, 2009.
8. Merck, The Merck Manual Online. http://www.merck.com/mmpe/sec20/ch303/ch303c.html (accessed April 5, 2012).
9. Widmainer, E.; Raff, H.; Strang, K., Vander's Human Physiology: The Mechanism of Body Function, 11th edn. McGraw-Hill, 2007.
10. Porter, C. J. H.; Charman, W. N., Intestinal lymphatic drug transport: an update. Adv. Drug Deliv. Rev. 50 (1-2), 61-80 (2001).
11. Atal, C. K.; Dubey, R. K.; Singh, J., Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism. J. Pharmacol. Exp. Ther. 232 (1), 258-262 (1985).
12. Bhardwaj, R. K.; Glaeser, H.; Becquemont, L.; Klotz, U.; Gupta, S. K.; Fromm, M. F., Piperine, a major constituent of black pepper, inhibits human p-glycoprotein and CYP3A4. J. Pharmacol. Exp. Ther. 302 (2), 645-650 (2002).
13. Wacher, V. J.; Salphati, L.; Benet, L. Z., Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv. Drug Deliv. Rev. 46 (1-3), 89-102 (2001).
14. Aggarwal, B. B.; Kumar, A.; Bharti, A. C., Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23 (1A), 363-398.
15. Joe, B.; Vijaykumar, M.; Lokesh, B. R., Biological properties of curcumin-cellular and molecular mechanisms of action. Crit. Rev. Food Sci. Nutr. 44 (2), 97-111 (2004).
16. Duvoix, A.; Blasius, R.; Delhalle, S.; Schnekenburger, M.; Morceau, F.; Henry, E.; Dicato, M.; Diederich, M., Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 223 (2), 181-190 (2005).
17. Sharma, R. A.; Gescher, A. J.; Steward, W. P., Curcumin: the story so far. Eur. J. Cancer 41 (13), 1955-1968 (2005).
18. Mou-Tuan, H.; Harold, L. N.; Krystyna, F., Inhibitory effects of curcumin on tumorigenesis in mice. J. Cell. Biochem. 67 (S27), 26-34 (1997).
19. Garcea, G.; Berry, D. P.; Jones, D. J. L.; Singh, R.; Dennison, A. R.; Farmer, P. B.; Sharma, R. A.; Steward, W. P.; Gescher, A. J., Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol. Biomark. Prev. 14 (1), 120-125 (2005).
20. Sharma, R. A.; McLelland, H. R.; Hill, K. A.; Ireson, C. R.; Euden, S. A.; Manson, M. M.; Pirmohamed, M.; Marnett, L. J.; Gescher, A. J.; Steward, W. P., Pharmacodynamic and pharmacokinetic study of oral curcuma extract in patients with colorectal cancer. Clin. Cancer Res. 7 (7), 1894-1900 (2001).
21. Hanai, H.; Iida, T.; Takeuchi, K.; Watanabe, F.; Maruyama, Y.; Andoh, A.; Tsujikawa, T.; Fujiyama, Y.; Mitsuyama, K.; Sata, M.; Yamada, M.; Iwaoka, Y.; Kanke, K.; Hiraishi, H.; Hirayama, K.; Arai, H.; Yoshii, S.; Uchijima, M.; Nagata, T.; Koide, Y., Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin. Gastroenterol. Hepatol. 4 (12), 1502-1506 (2006).
22. Anand, P.; Kunnumakkara, A. B.; Newman, R. A.; Aggarwal, B. B., Bioavailability of curcumin: problems and promises. Mol. Pharm. 4 (6), 807-818 (2007).
23. Lao, C.; Ruffin, M.; Normolle, D.; Heath, D.; Murray, S.; Bailey, J.; Boggs, M.; Crowell, J.; Rock, C.; Brenner, D., Dose escalation of a curcuminoid formulation. BMC Complement. Altern. Med. 6 (1), 10 (2006).
24. Kwon, G. S.; Okano, T., Polymeric micelles as new drug carriers. Adv. Drug Deliv. Rev. 21 (2), 107-116 (1996).
25. Yu, H.; Li, J.; Shi, K.; Huang, Q., Structure of modified epsilon-polylysine micelles and their application in improving cellular antioxidant activity of curcuminoids. Food Funct. 2, 373-380 (2011).
26. Yu, H.; Huang, Q., Enhanced in vitro anti-cancer activity of curcumin encapsulated in hydrophobically modified starch. Food Chem. 119 (2), 669-674 (2010).
27. Ma, Z. S.; Shayeganpour, A.; Brocks, D. R.; Lavasanifar, A.; Samuel, J., High-performance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin. Biomed. Chromatogr. 21 (5), 546-552 (2007).
28. Ma, Z. S.; Haddadi, A.; Molavi, O.; Lavasanifar, A.; Lai, R.; Samuel, J., Micelles of poly(ethylene oxide)-b-poly(ε-caprolactone) as vehicles for the solubilization, stabilization, and controlled delivery of curcumin. J. Biomed. Mater. Res. Part A 86A (2), 300-310 (2008).
29. Sou, K.; Oyajobi, B. O.; Goins, B.; Phillips, W. T.; Tsuchida, E., Characterization and cytotoxicity of self-organized assemblies of curcumin and amphiphatic poly(ethylene glycol). J. Biomed. Nanotechnol. 5 (2), 202-208 (2009).
30. Tønnesen, H. H., Solubility, chemical and photochemical stability of curcumin in surfactant solutions. Studies of curcumin and curcuminoids, XXVIII. Pharmazie 57 (12), 820-824 (2002).
31. Leung, M. H. A.; Colangelo, H.; Kee, T. W., Encapsulation of curcumin in cationic micelles suppresses alkaline hydrolysis. Langmuir 24 (11), 5672-5675 (2008).
32. Onoue, S.; Takahashi, H.; Kawabata, Y.; Seto, Y.; Hatanaka, J.; Timmermann, B.; Yamada, S., Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. J. Pharm. Sci. 99 (4), 1871-1881 (2010).
33. Porter, C. J. H.; Trevaskis, N. L.; Charman, W. N., Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov. 6 (3), 231-248 (2007).
34. Li, Y.; McClements, D. J., New mathematical model for interpreting pH-stat digestion profiles: impact of lipid droplet characteristics on in vitro digestibility. J. Agric. Food Chem. 58 (13), 8085-8092 (2010).
35. Yu, H.; Shi, K.; Liu, D.; Huang, Q., Development of a food-grade organogel with high bioaccessibility and loading of curcuminoids. Food Chem. 131, 48-54 (2012).
36. Lin, C. C.; Lin, H. Y.; Chen, H. C.; Yu, M. W.; Lee, M. H., Stability and characterisation of phospholipid-based curcumin-encapsulated microemulsions. Food Chem. 116 (4), 923-928 (2009).
37. Wang, X. Y.; Jiang, Y.; Wang, Y. W.; Huang, M. T.; Ho, C. T.; Huang, Q. R., Enhancing anti-inflammation activity of curcumin through O/W nanoemulsions. Food Chem. 108 (2), 419-424 (2008).
38. Ganta, S.; Amiji, M., Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol. Pharm. 6 (3), 928-939 (2009).
39. Lee, M. H.; Lin, H. Y.; Chen, H. C.; Thomas, J. L., Ultrasound mediates the release of curcumin from microemulsions. Langmuir 24 (5), 1707-1713 (2008).
40. Chirio, D.; Gallarate, M.; Trotta, M.; Carlotti, M. E.; Gaudino, E. C.; Cravotto, G., Influence of alpha-and gamma-cyclodextrin lipophilic derivatives on curcumin-loaded SLN. J. Incl. Phenom. Macrocycl. Chem. 65 (3-4), 391-402 (2009).
41. Sou, K.; Inenaga, S.; Takeoka, S.; Tsuchida, E., Loading of curcumin into macrophages using lipid-based nanoparticles. Int. J. Pharm. 352 (1-2), 287-293 (2008).
42. Tiyaboonchai, W.; Tungpradit, W.; Plianbangchang, P., Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int. J. Pharm. 337 (1-2), 299-306 (2007).
43. Yadav, V. R.; Suresh, S.; Devi, K.; Yadav, S., Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel disease. J. Pharm. Pharmacol. 61 (3), 311-321 (2009).
44. Shaikh, J.; Ankola, D. D.; Beniwal, V.; Singh, D.; Kumar, M., Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur. J. Pharm. Sci. 37 (3-4), 223-230 (2009).